	Adherence and weight loss with a total diet replacement programme for increased cancer risk associated with obesity: a UK cohort study. BMJ Open Clarke H, Lombardelli C, Barrett E, Wisely J, Sellers K, Issa B, Howell A, Davidson EJ, Howell S, Harvie M. PMID: 42805663 [PubMed - indexed for MEDLINE]
	Women in their 40s responding to the 2024 United States Preventive Services Task Force mammography guideline update: a focus group study. BMJ Open Scherer LD, Parmet T, Schapira MM, Cappella JN, Hersch J, McCaffery K, Lewis CL, Tate CE, Morse B. PMID: 42805646 [PubMed - indexed for MEDLINE]
	Abemaciclib and lenalidomide presenting with central retinal artery occlusion in a patient with breast cancer and multiple myeloma: a possible treatment-related association. BMJ Case Rep Pustake M, Ongsyping S, Gomez J, Corral J. PMID: 42805625 [PubMed - indexed for MEDLINE]
	Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer (CHN HYPOPMRT): 10-year outcomes from a randomised, non-inferiority, open-label, phase 3 trial. Lancet Oncol Sun GY, Chen SY, Tang Y, Fang H, Song YW, Liu YP, Jin J, Li N, Lu NN, Tang Y, Qi SN, Chen B, Jing H, Zhai YR, Zhang WW, Liu X, Yang ZB, Zhao XR, Song YC, Wang DQ, Wang SJ, Qiu ZH, Zhang CN, Yang SJ, Zhu JR, Liu JR, Shen XW, Hu C, Li YX, Wang SL. PMID: 42805199 [PubMed - indexed for MEDLINE]
	Trimethyl chitosan-hyaluronic acid nanoparticle-loaded hydrogel potentiates dendritic cell-based immunotherapy against breast cancer. Biochem Biophys Res Commun Eteghadi A, Taghipour N, Hosseinzadeh S, Hashemi SM, Ghasemi FS, Soleimani M. PMID: 42805013 [PubMed - as supplied by publisher]
	Performance of large language models in ambiguous treatment scenarios of early breast cancer. Breast Oseledchyk A, Weber WP, Kasenda B. PMID: 42804883 [PubMed - as supplied by publisher]
	Repurposing Gastric Cancer Biomarkers for Mucinous Ovarian Carcinoma: ERBB2 and Claudin 18.2 as Therapeutic Targets. Int J Gynecol Pathol Wang S, De Boeck A, Kang EY, Meagher NS, Gorringe KL, Nelson GS, Lee CH, Minoo P, Köbel M. PMID: 42804804 [PubMed - as supplied by publisher]
	Progression-free survival and overall survival in the first-line treatment of BRCA wild-type advanced epithelial ovarian cancer: An analysis of patient-level data pooled from historical clinical trials. Cancer Su L, Burcu M, Ports K, Gradinariu V, Itzkovich Y, Jain R, Yamada K, Tekin C, Chen L. PMID: 42804616 [PubMed - indexed for MEDLINE]
	Independent evaluation of machine learning and deep learning models for breast cancer detection. PLOS Digit Health Deepthi, Nayak A, Panicker RO. PMID: 42804475 [PubMed]
	Risk-reducing salpingo-oophorectomy in patients with gBRCA-mutated breast cancer. Arch Gynecol Obstet Amann N, Wagner K, Ziegler P, Krückel A, Brückner L, Gocke J, Müller C, Runz C, Heindl F, Hack CC, Emons J, Fasching AP, Beckmann WM, Hörner M. PMID: 42804048 [PubMed - indexed for MEDLINE]
	Circulating tumour DNA and its clinical relevance in predicting progression-free survival and overall survival in patients with advanced breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat Ottosen C, Kragelund E, Pedersen MA, Nguyen VQ, Khan SK, Larsen HB, Møller AL, Gamborg-Kvist SH, Spindler KG, Brems-Eskildsen AS, Callesen LB. PMID: 42804029 [PubMed - indexed for MEDLINE]
	Dermatologic adverse events associated with Sacituzumab Govitecan: an international retrospective study from the EADV Task Force "Dermatology for Cancer Patients" and pharmacovigilance analysis. Breast Cancer Res Treat Koumprentziotis IA, Cawley A, Ewig E, Gérard AO, Labat M, Kami, Kubeczko M, Rapparini L, Starace M, Grafanaki K, Kamaratou M, Mavroudis D, Katoulis A, Nikolaou V, Heelan K, Koumaki D. PMID: 42804021 [PubMed - indexed for MEDLINE]
	Association of miR-199a-3p and CDK7 expression with clinicopathological features of breast cancer. Mol Biol Rep Ibrahim NA, Hidayat HJ. PMID: 42804014 [PubMed - indexed for MEDLINE]
	HER2 status change in residual breast carcinoma after neoadjuvant HER2-targeted therapy in patients with HER2-positive breast cancer. Breast Cancer Res Treat Raval P, Ding Q, Singh P, Alrohaibani A, Sun H, Ai D, Wanis KN, Zhao M, Chen H, Valero V, Chavez-MacGregor M, Sahin A. PMID: 42803995 [PubMed - indexed for MEDLINE]
	Geographic access to triple negative breast cancer clinical trials: are trials located near patients? Breast Cancer Res Treat Amin LB, Kirkwood MK, Levit LA, Balogh EP, Waterhouse DM, Unger JM, Garrett-Mayer E, Chavez-MacGregor M. PMID: 42803985 [PubMed - indexed for MEDLINE]
	[Update on ovarian cancer]. Pathologie (Heidelb) Wimberger P, Link T. PMID: 42803933 [PubMed - as supplied by publisher]
	Clinical and Local Immune Factors Associated With Pleurodesis Outcomes in Breast Cancer Patients With Malignant Pleural Effusion: A Retrospective Study. Am J Hosp Palliat Care Yoshino M, Horimoto Y, Oshi M, Yamada A, Ushiyama Y, Ueki Y, Ishizuka Y, Hayashi T, Ishikawa T, Watanabe J, Kutomi G. PMID: 42803570 [PubMed - as supplied by publisher]
	Ultrasound-Based Breast Cancer Diagnosis Using Scale-Aware Modulation Meet Deep Dilated Convolutional Network With Weighted-Leader Search Optimization. Ultrason Imaging V B, Arunachalam KP, V D, Giri Prasad R. PMID: 42803427 [PubMed - as supplied by publisher]
	Pathologic complete response and residual disease after neoadjuvant chemotherapy in breast cancer: Comparison of contrast-enhanced mammography, DCE-MRI, and Â¹â¸F-FDG PET/CT. Biomol Biomed Ozan Sanhal E, Mutlu , Sürer Budak E, Vural V, Zihni , Sim, Sezgin Göksu S, Ar. PMID: 42803352 [PubMed - as supplied by publisher]
	Molecular insights into triazole-based compounds for triple-negative breast cancer treatment. J Enzyme Inhib Med Chem Vilangalil A, E S SP, Bukke SPN, V S, Meha N, Thalluri C, Daniel K, Ahikiriza AA. PMID: 42803315 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 335748

Page 1 of 16788



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy